Buy Stocks Easy | About Us
January 27, 2022
Buy Stocks Easy | Online Stocks

KMDA


Buy Kamada Ltd. Stock (symbol: KMDA) Easy Online

Company Name: Kamada Ltd.

Symbol: KMDA

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2013

KMDA Current Share Price

Today's KMDA ( Kamada Ltd. ) opening price: $6.9800

Yesterday's KMDA ( Kamada Ltd. ) closing price: $6.9600

Kamada Ltd. Stock ( symbol: KMDA ) Price Chart since IPO (2013):

12 Months Kamada Ltd. Stock ( symbol: KMDA ) Price Chart

Popular Questions about Kamada Ltd. Public Stock ( KMDA )

A: Kamada Ltd. stock symbol (also called stock or share ticker) is KMDA

A: Kamada Ltd. IPO (Initial Public Offering) took place on 2013

A: Kamada Ltd.'s stock (KMDA symbol) price at ther IPO (initial Public Offering) was $6.9800

Q: Is KMDA stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Kamada Ltd. stock (symbol: KMDA) at the beginning of 2019, at the opening share price of $5.2501, with a minimum of $200, by now your shares would be worth $7818 and your profit would be $7618 - SHOW ONLY IF PROFIT.

Buy Kamada Ltd. Stock Easy Online

Kamada Ltd. Stock Ticker Price Chart since IPO:





Kamada Ltd. Stock Price Yesterday



 


Kamada Ltd. Stock Price – Last Week




 


Kamada Ltd. Stock Price – Last Month




 


Kamada Ltd. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/16/1960826/0/en/Kamada-Announces-Enrollment-of-First-Patient-into-its-Pivotal-Phase-3-InnovAATe-Clinical-Trial-of-Inhaled-AAT-for-the-Treatment-of-Alpha-1-Antitrypsin-Deficiency.html
                            

                                
Kamada Announces Enrollment of First Patient into its Pivotal Phase 3 InnovAATe Clinical Trial of Inhaled AAT for the Treatment of Alpha-1 Antitrypsin Deficiency

                                
                                
REHOVOT, Israel, Dec.  16, 2019  (GLOBE NEWSWIRE) -- Kamada Ltd. (N...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1957778/0/en/Kamada-Enters-into-a-Binding-Term-Sheet-for-Contract-Manufacturing-of-an-FDA-Approved-Commercialized-Hyper-Immune-Globulin-Product.html
                            

                                
Kamada Enters into a Binding Term Sheet for Contract Manufacturing of an FDA Approved, Commercialized Hyper-Immune Globulin Product

                                
                                
REHOVOT, Israel, Dec.  09, 2019  (GLOBE NEWSWIRE) -- Kamada Ltd. (N...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/02/1954634/0/en/Kamada-Enters-into-Partnership-with-Alvotech-for-Commercialization-of-Six-Biosimilar-Products-in-Israel.html
                            

                                
Kamada Enters into Partnership with Alvotech for Commercialization of Six Biosimilar Products in Israel

                                
                                
REHOVOT, Israel, Dec.  02, 2019  (GLOBE NEWSWIRE) -- Kamada Ltd. (N...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4306462-kamada-ltd-kmda-ceo-amir-london-q3-2019-results-earnings-call-transcript
                            

                                
Kamada Ltd. (KMDA) CEO Amir London on Q3 2019 Results - Earnings Call Transcript

                                
                                
Kamada Ltd. (KMDA) CEO Amir London on Q3 2019 Results - Earnings Ca...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/617565/kamada-kmda-beats-q3-earnings-and-revenue-estimates
                            

                                
Kamada (KMDA) Beats Q3 Earnings and Revenue Estimates

                                
                                
Kamada (KMDA) delivered earnings and revenue surprises of 66.67% an...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/29/1936955/0/en/Kamada-and-Kedrion-Biopharma-Announce-Publication-of-Results-from-the-Registration-Study-of-KEDRAB-Rabies-Immune-Globulin-Human-in-Human-Vaccines-Immunotherapeutics-Medical-Journal.html
                            

                                
Kamada and Kedrion Biopharma Announce Publication of Results from the Registration Study of KEDRAB® (Rabies Immune Globulin [Human]) in Human Vaccines & Immunotherapeutics Medical Journal

                                
                                
The Successful Study was Basis for U.S. Food & Drug Administration ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/24/1919782/0/en/Kamada-to-Present-Corporate-Overview-at-the-2019-Cantor-Global-Healthcare-Conference.html
                            

                                
Kamada to Present Corporate Overview at the 2019 Cantor Global Healthcare Conference

                                
                                
REHOVOT, Israel, Sept.  24, 2019  (GLOBE NEWSWIRE) -- Kamada Ltd. (...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/459620/kamada-kmda-q2-earnings-and-revenues-surpass-estimates
                            

                                
Kamada (KMDA) Q2 Earnings and Revenues Surpass Estimates

                                
                                
Kamada (KMDA) delivered earnings and revenue surprises of 6.67% and...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/16/1960826/0/en/Kamada-Announces-Enrollment-of-First-Patient-into-its-Pivotal-Phase-3-InnovAATe-Clinical-Trial-of-Inhaled-AAT-for-the-Treatment-of-Alpha-1-Antitrypsin-Deficiency.html
                            

                                
Kamada Announces Enrollment of First Patient into its Pivotal Phase 3 InnovAATe Clinical Trial of Inhaled AAT for the Treatment of Alpha-1 Antitrypsin Deficiency

                                
                                
REHOVOT, Israel, Dec.  16, 2019  (GLOBE NEWSWIRE) -- Kamada Ltd. (N...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1957778/0/en/Kamada-Enters-into-a-Binding-Term-Sheet-for-Contract-Manufacturing-of-an-FDA-Approved-Commercialized-Hyper-Immune-Globulin-Product.html
                            

                                
Kamada Enters into a Binding Term Sheet for Contract Manufacturing of an FDA Approved, Commercialized Hyper-Immune Globulin Product

                                
                                
REHOVOT, Israel, Dec.  09, 2019  (GLOBE NEWSWIRE) -- Kamada Ltd. (N...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/02/1954634/0/en/Kamada-Enters-into-Partnership-with-Alvotech-for-Commercialization-of-Six-Biosimilar-Products-in-Israel.html
                            

                                
Kamada Enters into Partnership with Alvotech for Commercialization of Six Biosimilar Products in Israel

                                
                                
REHOVOT, Israel, Dec.  02, 2019  (GLOBE NEWSWIRE) -- Kamada Ltd. (N...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4306462-kamada-ltd-kmda-ceo-amir-london-q3-2019-results-earnings-call-transcript
                            

                                
Kamada Ltd. (KMDA) CEO Amir London on Q3 2019 Results - Earnings Call Transcript

                                
                                
Kamada Ltd. (KMDA) CEO Amir London on Q3 2019 Results - Earnings Ca...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/617565/kamada-kmda-beats-q3-earnings-and-revenue-estimates
                            

                                
Kamada (KMDA) Beats Q3 Earnings and Revenue Estimates

                                
                                
Kamada (KMDA) delivered earnings and revenue surprises of 66.67% an...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/29/1936955/0/en/Kamada-and-Kedrion-Biopharma-Announce-Publication-of-Results-from-the-Registration-Study-of-KEDRAB-Rabies-Immune-Globulin-Human-in-Human-Vaccines-Immunotherapeutics-Medical-Journal.html
                            

                                
Kamada and Kedrion Biopharma Announce Publication of Results from the Registration Study of KEDRAB® (Rabies Immune Globulin [Human]) in Human Vaccines & Immunotherapeutics Medical Journal

                                
                                
The Successful Study was Basis for U.S. Food & Drug Administration ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/24/1919782/0/en/Kamada-to-Present-Corporate-Overview-at-the-2019-Cantor-Global-Healthcare-Conference.html
                            

                                
Kamada to Present Corporate Overview at the 2019 Cantor Global Healthcare Conference

                                
                                
REHOVOT, Israel, Sept.  24, 2019  (GLOBE NEWSWIRE) -- Kamada Ltd. (...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/459620/kamada-kmda-q2-earnings-and-revenues-surpass-estimates
                            

                                
Kamada (KMDA) Q2 Earnings and Revenues Surpass Estimates

                                
                                
Kamada (KMDA) delivered earnings and revenue surprises of 6.67% and...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.